Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Parya Saberi, PharmD

    TitleAssistant Professor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address550 16th Street, 3rd Floor
    San Francisco CA 94158
    Phone415-476-6357

       Biography 
       Education and Training
      University of California, San FranciscoM.A.S. in Clinical Research Graduate Division (Advance Training in Clinical Research)2011
      University of California, San Francisco Residency

       Overview 
       Overview
      Parya Saberi, PharmD, MAS is an Assistant Professor at the Center for AIDS Prevention Studies in the Department of Medicine at the University of California, San Francisco. She is also an HIV Clinical Pharmacist at Ward 86 (Positive Health Program) at San Francisco General Hospital. Dr. Saberi's is funded by the National Institute of Mental Health through a K23 Mentored Patient-oriented Research Career Development Award. Her current area of research includes adapting technology-based strategies to improve antiretroviral adherence and engagement in HIV Care among HIV-positive youth. These methods include social networking technologies, video-conferencing tools, and text messaging. Additionally, she is involved in the development of an index of engagement in HIV care as well as research regarding retention and adherence to HIV care in South Africa.


       ORNG Applications 
       Websites
       Awarded Grants
       Global Health

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Saberi P, Neilands TB, Vittinghoff E, Johnson MO, Chesney M, Cohn SE. Barriers to Antiretroviral Therapy Adherence and Plasma HIV RNA Suppression Among AIDS Clinical Trials Group Study Participants. AIDS Patient Care STDS. 2015 Mar; 29(3):111-6.
        View in: PubMed
      2. Saberi P, Mayer K, Vittinghoff E, Naar-King S. Correlation Between Use of Antiretroviral Adherence Devices by HIV-Infected Youth and Plasma HIV RNA and Self-Reported Adherence. AIDS Behav. 2015 Jan; 19(1):93-103.
        View in: PubMed
      3. Saberi P, Johnson MO. Moving toward a novel and comprehensive behavioral composite of engagement in HIV care. AIDS Care. 2015 May; 27(5):660-4.
        View in: PubMed
      4. Saberi P, Neilands TB, Johnson MO. Association between dog guardianship and HIV clinical outcomes. J Int Assoc Provid AIDS Care. 2014 Jul-Aug; 13(4):300-4.
        View in: PubMed PMC3995900
      5. Yuan P, Bare MG, Johnson MO, Saberi P. Using online social media for recruitment of human immunodeficiency virus-positive participants: a cross-sectional survey. J Med Internet Res. 2014; 16(5):e117.
        View in: PubMed PMC4026571
      6. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82.
        View in: PubMed PMC4054817
      7. Cocohoba J, Dong BJ, Johnson MO, Saberi P. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85.
        View in: PubMed PMC4112174
      8. Saberi P, Yuan P, John M, Sheon N, Johnson MO. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDS. 2013 Sep; 27(9):529-32.
        View in: PubMed PMC3760070
      9. Saberi P, Comfort M, Sheon N, Johnson MO. Qualitative study of the quality of sleep in marginalized individuals living with HIV. Patient Prefer Adherence. 2013; 7:499-507.
        View in: PubMed PMC3687846
      10. Saberi P, Phengrasamy T, Nguyen DP. Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management. HIV Med. 2013 Oct; 14(9):519-29.
        View in: PubMed PMC3758391
      11. Saberi P, Gamarel KE, Neilands TB, Comfort M, Sheon N, Darbes LA, Johnson MO. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012; 7(11):e50061.
        View in: PubMed PMC3498189
      12. Bruno C, Saberi P. Pharmacists as providers of HIV pre-exposure prophylaxis. Int J Clin Pharm. 2012 Dec; 34(6):803-6.
        View in: PubMed PMC3501608
      13. Saberi P, Caswell NH, Jamison R, Estes M, Tulsky JP. Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. J Urban Health. 2012 Oct; 89(5):794-801.
        View in: PubMed PMC3462822
      14. Saberi P, Comfort M, Johnson MO. The relationship between daily organization and adherence to antiretroviral therapy: a qualitative perspective. J Acquir Immune Defic Syndr. 2012 Sep 1; 61(1):e3-6.
        View in: PubMed PMC3427530
      15. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404.
        View in: PubMed PMC3363300
      16. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322.
        View in: PubMed PMC3333818
      17. Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011; 6(11):e27533.
        View in: PubMed PMC3227571
      18. Saberi P, Johnson MO, McCulloch CE, Vittinghoff E, Neilands TB. Medication adherence: tailoring the analysis to the data. AIDS Behav. 2011 Oct; 15(7):1447-53.
        View in: PubMed PMC3216469
      19. Saberi P, Neilands TB, Johnson MO. Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS. 2011 Sep; 25(9):517-24.
        View in: PubMed PMC3157301
      20. Bruno CB, Schapiro JM, Saberi P. An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature. J Int Assoc Physicians AIDS Care (Chic). 2011 Jul-Aug; 10(4):219-22.
        View in: PubMed PMC3222949
      21. Saberi P, Ranatunga DK, Quesenberry CP, Silverberg MJ. Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy. 2011 Mar; 31(3):253-61.
        View in: PubMed PMC3091502
      22. Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care. 2010 Oct; 22(10):1189-94.
        View in: PubMed
      23. Saberi P, Caswell N, Amodio-Groton M, Alpert P. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care. 2008 Jul; 20(6):741-5.
        View in: PubMed
      24. Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. Ann Pharmacother. 2008 May; 42(5):621-6.
        View in: PubMed
      Parya's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP